707
Views
26
CrossRef citations to date
0
Altmetric
Review

Asymptomatic malaria in the clinical and public health context

, , , , &
Pages 997-1010 | Received 20 Aug 2019, Accepted 12 Nov 2019, Published online: 21 Nov 2019

References

  • World Health Organization. A framework for malaria elimination. 2017. [cited 2019 Apr 27]. Available from: https://www.who.int/malaria/publications/atoz/9789241511988/en/
  • Roll back malaria partnership. Roll back malaria partnership to end malaria 2018. [cited 2018 Aug 12]. Available from: https://endmalaria.org/
  • Lindblade KA, Steinhardt L, Samuels A, et al. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther. 2013;11(6):623–639.
  • Bousema T, Okell L, Felger I, et al. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nature Rev Microbiol. 2014;12;12(12):833–840.
  • Okell LC, Bousema T, Griffin JT, et al. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.
  • World Health Organization. World Malaria Report 2018. [cited 2019 Mar 15]. Available from: https://www.who.int/malaria/publications/world-malaria-report-2018/report/en/
  • World Health Organization. Global technical strategy for malaria 2016–2030. 2015. [cited 2019 Apr 28]. Available from: https://www.who.int/malaria/publications/atoz/9789241564991/en/
  • United Nations. Sustainable development goals. 2015. [cited 2018 Aug 18]. Available from: http://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&Lang=E
  • United Nations. Sustainable development goal 3: ensure healthy lives and promote well-being for all at all ages. 2018. [cited 2019 Apr 27]. Available from: https://sustainabledevelopment.un.org/sdg3
  • World Health Organization. Update on the E-2020 initiative of 21 malaria-eliminating countries: report and country briefs. World Health Organization; 2018. [cited 2019 Apr 27]. Available from: https://www.who.int/malaria/publications/atoz/e-2020-progress-report/en/
  • World Health Organization. WHO malaria terminology. 2016. [cited 2019 Apr 27]. Available from: https://www.who.int/malaria/publications/atoz/malaria-terminology/en/
  • Chen I, Clarke SE, Gosling R, et al. “Asymptomatic” malaria: a chronic and debilitating infection that should be treated. PLoS Med/Public Lib Sci. 2016;13(1):e1001942.
  • Sattabongkot J, Suansomjit C, Nguitragool W, et al. Prevalence of asymptomatic Plasmodium infections with sub-microscopic parasite densities in the northwestern border of Thailand: a potential threat to malaria elimination. Malar J. 2018;17(1):329.
  • Wamae K, Wambua J, Nyangweso G, et al. Transmission and age impact the risk of developing febrile malaria in children with asymptomatic Plasmodium falciparum Parasitemia. J Infect Dis. 2019;219(6):936–944.
  • Imwong M, Stepniewska K, Tripura R, et al. Numerical distributions of parasite densities during asymptomatic malaria. J Infect Dis. 2016;213(8):1322–1329.
  • White NJ. Malaria parasite clearance. Malar J. 2017 feb 23;16(1):88.
  • Slater HC, Ross A, Felger I, et al. The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density. Nat Commun. 2019;10(1):1433.
  • Bruce MC, Donnelly CA, Packer M, et al. Age- and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea. Parasitology. 2000;121(3):247–256.
  • Roucher C, Rogier C, Sokhna C, et al. A 20-year longitudinal study of Plasmodium ovale and Plasmodium malariae prevalence and morbidity in a West African population. PLoS ONE. 2014;9(2):e87169.
  • Faye FBK, Spiegel A, Tall A, et al. Diagnostic criteria and risk factors for Plasmodium ovale malaria. J Infect Dis. 2002;186(5):690–695.
  • Doolan DL, Dobaño C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22(1):13–36.
  • Beier JC, Killeen GF, Githure JI. Entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Am J Trop Med Hyg. 1999;61(1):109–113.
  • Rek J, Katrak S, Obasi H, et al. Characterizing microscopic and submicroscopic malaria parasitaemia at three sites with varied transmission intensity in Uganda. Malar J. 2016;15:470.
  • Dobbs KR, Dent AE. Plasmodium malaria and antimalarial antibodies in the first year of life. Parasitology. 2016;143(2):129–138.
  • Felger I, Maire M, Bretscher MT, et al. The dynamics of natural Plasmodium falciparum infections. PloS One. 2012;7(9):e45542.
  • Hofmann NE, Karl S, Wampfler R, et al. The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea. Elife. 2017;6:e23708.
  • Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(6):457–468.
  • Williams TN, Mwangi TW, Wambua S, et al. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis. 2005;192(1):178–186.
  • Mangano VD, Kabore Y, Bougouma EC, et al. Novel insights into the protective role of hemoglobin S and C against Plasmodium falciparum Parasitemia. J Infect Dis. 2015;212(4):626–634.
  • Gonçalves BP, Sagara I, Coulibaly M, et al. Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential. Sci Rep. 2017;7(1):14267.
  • Lamptey H, Ofori MF, Adu B, et al. Association between alpha-thalassaemia trait, Plasmodium falciparum asexual parasites and gametocyte carriage in a malaria endemic area in Southern Ghana. BMC Res Notes. 2019;12(1):134.
  • Degarege A, Gebrezgi MT, Beck-Sague CM, et al. Effect of ABO blood group on asymptomatic, uncomplicated and placental Plasmodium falciparum infection: systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):86.
  • Gonçalves BP, Kapulu MC, Sawa P, et al. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity. Nat Commun. 2017;8(1):1133.
  • Clark EH, Silva CJ, Weiss GE, et al. Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory. Infect Immun. 2012;80(4):1583–1592.
  • CDC - Centers for Disease Control and Prevention. About malaria - biology. 2018. [cited 2019 Apr 27]. Available from: https://www.cdc.gov/malaria/about/biology/index.html
  • Bousema T, Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011;24(2):377–410.
  • Tadesse FG, Slater HC, Chali W, et al. The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia. Clinl Infect Dis. 2018;66(12):1883–1891.
  • Vantaux A, Samreth R, Piv E, et al. Contribution to malaria transmission of symptomatic and asymptomatic parasite carriers in Cambodia. J Infect Dis. 2018;217(10):1561–1568.
  • Gaye A, Bousema T, Libasse G, et al. Infectiousness of the human population to Anopheles arabiensis by direct skin feeding in an area hypoendemic for malaria in Senegal. Am J Trop Med Hyg. 2015;92(3):648–652.
  • Hofmann NE, Gruenberg M, Nate E, et al. Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study. Lancet Infect Dis. 2018;18(10):1108–1116.
  • Da DF, Churcher TS, Yerbanga RS, et al. Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions. Exp Parasitol. 2015;149:74–83.
  • Kiattibutr K, Roobsoong W, Sriwichai P, et al. Infectivity of symptomatic and asymptomatic Plasmodium vivax infections to a Southeast Asian vector, Anopheles dirus. Int J Parasitol. 2017;47(2–3):163–170.
  • Ouedraogo AL, Goncalves BP, Gneme A, et al. Dynamics of the human infectious reservoir for malaria determined by mosquito feeding assays and ultrasensitive malaria diagnosis in Burkina Faso. J Infect Dis. 2016;213(1):90–99.
  • Koepfli C, Robinson LJ, Rarau P, et al. Blood-stage parasitaemia and age determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea. PLoS ONE. 2015;10(5):e0126747.
  • AK G, AD B-B, Beier M, et al. The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Trans R Soc Trop Med Hyg. 1992;86(4):355–358.
  • Coleman RE, Kumpitak C, Ponlawat A, et al. Infectivity of asymptomatic Plasmodium-infected human populations to Anopheles dirus mosquitoes in western Thailand. J Med Entomol. 2004;41(2):201–208.
  • Lin JT, Ubalee R, Lon C, et al. Microscopic Plasmodium falciparum Gametocytemia and infectivity to mosquitoes in Cambodia. J Infect Dis. 2016;213(9):1491–1494.
  • Goncalves BP, Drakeley C, Bousema T. Infectivity of microscopic and submicroscopic malaria parasite infections in areas of low malaria endemicity. J Infect Dis. 2016;213(9):1516–1517.
  • Stone W, Goncalves BP, Bousema T, et al. Assessing the infectious reservoir of falciparum malaria: past and future. Trends Parasitol. 2015;31(7):287–296.
  • Zhong D, Koepfli C, Cui L, et al. Molecular approaches to determine the multiplicity of Plasmodium infections. Malar J. 2018;17(1):172.
  • Botwe AK, Asante KP, Adjei G, et al. Dynamics in multiplicity of Plasmodium falciparum infection among children with asymptomatic malaria in central Ghana. BMC Genet. 2017;18(1):67.
  • Mohd Abd Razak MR, UR S, NA N, et al. Genetic diversity of Plasmodium falciparum populations in malaria declining areas of Sabah, East Malaysia. PLoS One. 2016;11(3):e0152415.
  • Nag S, Kofoed P-E, Ursing J, et al. Direct whole-genome sequencing of Plasmodium falciparum specimens from dried erythrocyte spots. Malar J. 2018;17(1):91.
  • Lerch A, Koepfli C, Hofmann NE, et al. Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections. BMC Genomics. 2017; 18(1):864.
  • Akter J, Thriemer K, Khan WA, et al. Genotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh. Malar J. 2012;11:386.
  • Lerch A, Koepfli C, Hofmann NE, et al. Longitudinal tracking and quantification of individual Plasmodium falciparum clones in complex infections. Sci Rep. 2019;9(1):3333.
  • Gatei W, Gimnig JE, Hawley W, et al. Genetic diversity of Plasmodium falciparum parasite by microsatellite markers after scale-up of insecticide-treated bed nets in western Kenya. Malar J. 2015;13(Suppl 1):495.
  • Araia Berhane KA, Mihreteab S, Gresty K, et al. Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, eritrea. Emerg Infect Dis. 2018;24(3):462.
  • Hathaway NJ, Parobek CM, Juliano JJ, et al. SeekDeep: single-base resolution de novo clustering for amplicon deep sequencing. Nucleic Acids Res. 2018;46(4):e21–e21.
  • Long Q, Jeffares DC, Zhang Q, et al. PoolHap: inferring haplotype frequencies from pooled samples by next generation sequencing. Plos One. 2011;6(1):e15292.
  • Zhu SJ, Almagro-Garcia J, McVean G. Deconvolution of multiple infections in Plasmodium falciparum from high throughput sequencing data. Bioinformatics. 2018;34(1):9–15.
  • Talundzic E, Ravishankar S, Kelley J, et al. Next-generation sequencing and bioinformatics protocol for malaria drug resistance marker surveillance. Antimicrob Agents Chemother. 2018;62:4.
  • Ayogu EE, Ukwe CV, Nna EO. Assessing the reliability of microscopy and rapid diagnostic tests in malaria diagnosis in areas with varying parasite density among older children and adult patients in Nigeria. J Postgrad Med. 2016;62(3):150–156.
  • McMorrow ML, Aidoo M, Kachur SP. Malaria rapid diagnostic tests in elimination settings—can they find the last parasite? Clin Microbiol Infect. 2011;17(11):1624–1631.
  • Mathison BA, Pritt BS. Update on malaria diagnostics and test utilization. J Clin Microbiol. 2017;55(7):2009–2017.
  • Boyce MR, O’Meara WP. Use of malaria RDTs in various health contexts across sub-Saharan Africa: a systematic review. BMC Public Health. 2017;17(1): 470.
  • Kilian AH, Metzger WG, Mutschelknauss EJ, et al. Reliability of malaria microscopy in epidemiological studies: results of quality control. Trop Med Int Health. 2000;5(1):3–8.
  • Pollak JJ, Houri-Yafin A, Salpeter SJ. Computer vision malaria diagnostic systems—progress and prospects. Front Public Health. 2017;5:219.
  • Torres K, Bachman CM, Delahunt CB, et al. Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru. Malar J. 2018;17(1):339.
  • Girma S, Cheaveau J, Mohon AN, et al. Prevalence and epidemiological characteristics of asymptomatic malaria based on ultrasensitive diagnostics: A cross-sectional study. Clinl Infect Dis. 2018;26:26.
  • Mukkala AN, Kwan J, Lau R, et al. An update on malaria rapid diagnostic tests. Curr Infect Dis Rep. 2018;20(12):49.
  • World Health Organization. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions. 2019.[cited 2019 Apr 27]. Available from: https://www.who.int/malaria/publications/atoz/information-note-hrp2-based-rdt/en/
  • Das S, Jang IK, Barney B, et al. Performance of a high-sensitivity rapid diagnostic test for Plasmodium falciparum malaria in asymptomatic individuals from Uganda and Myanmar and naive human challenge infections. Am J Trop Med Hyg. 2017;97(5):1540–1550.
  • Landier J, Haohankhunnatham W, Das S, et al. Operational performance of a Plasmodium falciparum ultrasensitive rapid diagnostic test for detection of asymptomatic infections in Eastern Myanmar. J Clin Microbiol. 2018 08;56(8):08.
  • Dalrymple U, Arambepola R, Gething PW, et al. How long do rapid diagnostic tests remain positive after anti-malarial treatment? Malar J. 2018;17(1):228.
  • Meatherall B, Preston K, Pillai DR. False positive malaria rapid diagnostic test in returning traveler with typhoid fever. BMC Infect Dis. 2014;14:377.
  • Singh B, Bobogare A, Cox-Singh J, et al. A genus-and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 1999;60(4):687–692.
  • Kamau E, Alemayehu S, Feghali KC, et al. Multiplex qPCR for detection and absolute quantification of malaria. PLoS One. 2013;8(8):e71539.
  • Zainabadi K, Adams M, Han ZY, et al. A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections. Malar J. 2017;16(1):377.
  • Mohon AN, Lee LD-Y, Bayih AG, et al. NINA-LAMP compared to microscopy, RDT, and nested PCR for the detection of imported malaria. Diagn Microbiol Infect Dis. 2016;85(2):149–153.
  • Kemleu S, Guelig D, Eboumbou Moukoko C, et al. A field-tailored reverse transcription loop-mediated isothermal assay for high sensitivity detection of Plasmodium falciparum infections. PLoS ONE. 2016;11(11):e0165506.
  • Schoone GJ, Oskam L, Kroon NC, et al. Detection and quantification of Plasmodium falciparumin blood samples using quantitative nucleic acid sequence-based amplification. J Clin Microbiol. 2000;38(11):4072–4075.
  • Mens PF, Schoone GJ, Kager PA, et al. Detection and identification of human Plasmodium species with real-time quantitative nucleic acid sequence-based amplification. Malar J. 2006;5(1):80.
  • Imwong M, Hanchana S, Malleret B, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52(9):3303–3309.
  • Li Y, Kumar N, Gopalakrishnan A, et al. Detection and species identification of malaria parasites by isothermal tHDA amplification directly from human blood without sample preparation. J Mol Diagn. 2013;15(5):634–641.
  • Imai K, Tarumoto N, Misawa K, et al. A novel diagnostic method for malaria using loop-mediated isothermal amplification (LAMP) and MinION™ nanopore sequencer. BMC Infect Dis. 2017;17(1):621.
  • Hofmann N, Mwingira F, Shekalaghe S, et al. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med/Public Lib Sci. 2015;12(3):e1001788.
  • Marti H, Stalder C, González IJ. Diagnostic accuracy of a LAMP kit for diagnosis of imported malaria in Switzerland. Travel Med Infect Dis. 2015;13(2):167–171.
  • Ponce C, Kaczorowski F, Perpoint T, et al. Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for screening patients with imported malaria in a non-endemic setting. Parasite. 2017;24:53.
  • Rypien C, Chow B, Chan WW, et al. Detection of Plasmodium Infection by the illumigene malaria assay compared to reference microscopy and real-time PCR. J Clin Microbiol. 2017;55(10):3037–3045.
  • Cheaveau J, Nguyen H, Chow B, et al. Clinical validation of a commercial LAMP test for ruling out malaria in returning travelers: a prospective diagnostic trial. Open Forum Infect Dis. 2018;5(11):ofy260.
  • Aydin-Schmidt B, Morris U, XC D, et al. Field evaluation of a high throughput loop mediated isothermal amplification test for the detection of asymptomatic Plasmodium infections in Zanzibar. PLoS ONE. 2017;12(1):e0169037.
  • Lucchi NW, Gaye M, Diallo MA, et al. Evaluation of the illumigene malaria LAMP: a robust molecular diagnostic tool for malaria parasites. Sci Rep. 2016;6:36808.
  • Poon LL, Wong BW, Ma EH, et al. Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin Chem. 2006;52(2):303–306.
  • Bretscher MT, Maire N, Felger I, et al. Asymptomatic Plasmodium falciparum infections may not be shortened by acquired immunity. Malar J. 2015 Aug;04(14):294.
  • Nguyen TN, von Seidlein L, Nguyen TV, et al. The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study. Lancet Infect Dis. 2018 05;18(5):565–572.
  • Buchwald AG, Sixpence A, Chimenya M, et al. Clinical implications of asymptomatic Plasmodium falciparum infections in Malawi. Clinl Infect Dis. 2019;68(1):106–112.
  • Bjorkman AB. Asymptomatic low-density malaria infections: a parasite survival strategy? Lancet Infect Dis. 2018. 05; 18(5):485–486.
  • White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10(1):297.
  • Searle KM, Katowa B, Kobayashi T, et al. Distinct parasite populations infect individuals identified through passive and active case detection in a region of declining malaria transmission in southern Zambia. Malar J. 2017;16(1):154.
  • Koepfli C, Mueller I. Malaria epidemiology at the clone level. Trends Parasitol. 2017;33(12):974–985.
  • Dondorp AM, White LJ, White NJ, et al. Infectivity of chronic malaria infections and its consequences for control and elimination. Clinl Infect Dis. 2018;67(2):295–302.
  • Sondén K, Doumbo S, Hammar U, et al. Asymptomatic multiclonal Plasmodium falciparum infections carried through the dry season predict protection against subsequent clinical malaria. J Infect Dis. 2015;212(4):608–616.
  • Pérignon JL, Druilhe P. Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Memorias Do Instituto Oswaldo Cruz. 1994;89(Suppl 2):51–53.
  • Portugal S, TM T, Ongoiba A, et al. Treatment of chronic asymptomatic Plasmodium falciparum infection does not increase the risk of clinical malaria upon reinfection. Clinl Infect Dis. 2016;64(5):645–653.
  • White NJ. The consequences of treating asymptomatic malaria Parasitemia. Clinl Infect Dis. 2017;64(5):654–655.
  • Cottrell G, Moussiliou A, Luty AJF, et al. Submicroscopic Plasmodium falciparum infections are associated with maternal anemia, premature births, and low birth weight. Clinl Infect Dis. 2015;60(10):1481–1488.
  • Kurtzhals JAL, Addae MM, Akanmori BD, et al. Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren. Trans R Soc Trop Med Hyg. 1999;93(6):623–627.
  • Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ. 1983;61(6):1005–1016.
  • World Health Organization. Malaria in pregnant women. 2018. [cited 2019 Apr 27]. Available from: https://www.who.int/malaria/areas/high_risk_groups/pregnancy/en/
  • Athuman M, Kabanywanyi AM, Rohwer AC. Intermittent preventive antimalarial treatment for children with anaemia. Cochrane Db Syst Rev. 2015;1.
  • Sifft KC, Geus D, Mukampunga C, et al. Asymptomatic only at first sight: malaria infection among schoolchildren in highland Rwanda. Malar J. 2016;15(1):553.
  • Abdulkareem BO, Adam AO, Ahmed AO, et al. Malaria-induced anaemia and serum micronutrients in asymptomatic Plasmodium falciparum infected patients. J Parasitic Dis. 2017;41(4):1093–1097.
  • Pava Z, Burdam FH, Handayuni I, et al. Submicroscopic and asymptomatic Plasmodium Parasitaemia associated with significant risk of anaemia in Papua, Indonesia. PLoS ONE. 2016;11(10):e0165340.
  • Clarke SE, Jukes MCH, Njagi JK, et al. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9633):127–138.
  • Boivin MJ, Sikorskii A, Familiar-Lopez I, et al. Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children. Malar J. 2016;15:210.
  • Mooney JP, Galloway LJ, Riley EM. Malaria, anemia, and invasive bacterial disease: A neutrophil problem? J Leukoc Biol. 2019;105(4):645–655.
  • Takem EN, Roca A, Cunnington A. The association between malaria and non-typhoid Salmonella bacteraemia in children in sub-Saharan Africa: a literature review. Malar J. 2014;13:400.
  • Burdam FH, Hakimi M, Thio F, et al. Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: major risk factors for anaemia in early life. PLoS ONE. 2016;11(8):e0160917.
  • Ojurongbe O, Adegbayi AM, Bolaji OS, et al. Asymptomatic falciparum malaria and intestinal helminths co-infection among school children in Osogbo, Nigeria. J Res Med Sci. 2011;16(5):680–686.
  • Sturrock HJW, Hsiang MS, Cohen JM, et al. Targeting asymptomatic malaria infections: active surveillance in control and elimination. PLoS Med. 2013;10(6):e1001467.
  • World Health Organization. Mass drug administration, mass screening and treatment and focal screening and treatment for malaria. 2015. [cited 2019 Apr 27]. Available from: https://www.who.int/malaria/mpac/mpac-sept2015-erg-mda-report.pdf
  • Bousema T, Griffin JT, Sauerwein RW, et al. Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med. 2012;9(1):e1001165.
  • Poirot E, Skarbinski J, Sinclair D, et al. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;(12):Cd008846
  • Newby G, Hwang J, Koita K, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93(1):125–134.
  • Landier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81.
  • von Seidlein L, Peto TJ, Landier J, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial. PLoS Med/Public Lib Sci. 2019 Feb;16(2):e1002745.
  • Pell C, Tripura R, Nguon C, et al. Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage. Malar J. 2017 May 19;16(1):206.
  • Adhikari B, Phommasone K, Pongvongsa T, et al. Perceptions of asymptomatic malaria infection and their implications for malaria control and elimination in Laos. PLoS ONE. 2018;13(12):e0208912.
  • White NJ. Does antimalarial mass drug administration increase or decrease the risk of resistance? Lancet Infect Dis. 2017 Jan 01;17(1):e15–e20.
  • Larsen DA, Bennett A, Silumbe K, et al. Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern Zambia: a community randomized step-wedge control trial design. Am J Trop Med Hyg. 2015;92(5):913–921.
  • Cook J, Xu W, Msellem M, et al. Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar. J Infect Dis. 2015 May 1;211(9):1476–1483.
  • Sutanto I, Kosasih A, Elyazar IRF, et al. Negligible impact of mass screening and treatment on mesoendemic malaria transmission at West Timor in Eastern Indonesia: a cluster-randomized trial. Clin Infect Dis. 2018;67(9):1364–1372.
  • Perera RS, Ding XC, Tully F, et al. Development and clinical performance of high throughput loop-mediated isothermal amplification for detection of malaria. PloS One. 2017;12(2):e0171126.
  • Tambo M, Auala JR, Sturrock HJ, et al. Evaluation of loop-mediated isothermal amplification as a surveillance tool for malaria in reactive case detection moving towards elimination. Malar J. 2018;17(1):255.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.